Evidence map›Paper›PMID 38416198›Full record

ArticleJournal of neural transmission (Vienna, Austria : 1996)2024

NFKB1 variants were associated with the risk of Parkinson´s disease in male.

Sergio Perez-Oliveira, Daniel Vazquez-Coto, Sara Pardo, Marta Blázquez-Estrada, Manuel Menéndez-González, Pablo Siso, Esther Suárez, Ciara García-Fernández, Beatriz de la Casa Fages, Eliecer Coto and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neural transmission (Vienna, Austria : 1996), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Sergio Perez-Oliveira *Laboratorio de Genética, Hospital Universitario Central de Asturias, Avd de Roma s/n, Oviedo, 33011, Spain.
Daniel Vazquez-Coto *Laboratorio de Genética, Hospital Universitario Central de Asturias, Avd de Roma s/n, Oviedo, 33011, Spain.
Sara PardoLaboratorio de Genética, Hospital Universitario Central de Asturias, Avd de Roma s/n, Oviedo, 33011, Spain.
Marta Blázquez-EstradaInstituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Manuel Menéndez-GonzálezInstituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Pablo SisoInstituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Esther SuárezInstituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Ciara García-FernándezInstituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Beatriz de la Casa FagesServicio de Neurología, Hospital Universitario Gregorio Marañon, Madrid, Spain.
Eliecer CotoLaboratorio de Genética, Hospital Universitario Central de Asturias, Avd de Roma s/n, Oviedo, 33011, Spain.
Victoria ÁlvarezLaboratorio de Genética, Hospital Universitario Central de Asturias, Avd de Roma s/n, Oviedo, 33011, Spain. victoria.alvarez@sespa.es.
Hospital Universitario Central de Asturias · ESInstituto de Investigación Sanitaria del Principado de Asturias · ESHospital General Universitario Gregorio Marañón · ES

Funding

Instituto de Salud Carlos III P21/0467
6 · The paper itself

Abstract

The NF-κB pathway is involved in the pathogenesis of neurological disorders that have inflammation as a hallmark, including Parkinson's disease (PD). Our objective was to determine whether common functional variants in the NFKB1, NFKBIA and NFKBIZ genes were associated with the risk of PD. A total of 532 Spanish PD cases (61% male; 38% early-onset, ≤ 55 years) and 300 population controls (50% ≤55 years) were genotyped for the NFKB1 rs28362491 and rs7667496, NFKBIA rs696, and NFKBIZ rs1398608 polymorphisms. We compared allele and genotype frequencies between early and late-onset, male and female, and patient's vs. controls. We found that the two NFKB1 alleles were significantly associated with PD in our population (p = 0.01; total patients vs. controls), without difference between Early and Late onset patients. The frequencies of the NFKB1 variants significantly differ between male and female patients. Compared to controls, male patients showed a significantly higher frequency of rs28362491 II (p = 0.02, OR = 1.52, 95%CI = 1.10-2.08) and rs28362491 C (p = 0.003, OR = 1.62, 95%CI = 1.18-2.22). The two NFKB1 variants were in strong linkage disequilibrium and the I-C haplotype was significantly associated with the risk of PD among male (p = 0.002). In conclusion, common variants in the NF-kB genes were associated with the risk of developing PD in our population, with significant differences between male and female. These results encourage further studies to determine the involvement of the NF-kB components in the pathogenesis of Parkinson´s disease.

Indexed as

Genetic Predisposition to DiseaseNF-kappa B p50 SubunitParkinson DiseaseAdultAgedFemaleGene FrequencyGenetic Association StudiesGenotypeHumansMaleMiddle AgedPolymorphism, Single NucleotideSex FactorsSpainNF-kappa B p50 SubunitNFKB1 protein, humanGene polymorphismsGenetic susceptibiltyNuclear-factor kappa-bParkinson´s disease

Identifiers

PMID38416198
OpenAlexW4392234174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.